Stent patency using competing risk model in unresectable pancreatic cancers inserted with biliary self-expandable metallic stent
Digestive Endoscopy, 06/15/2012
Eem YO et al. – The patency of biliary self–expandable metallic stents (SEMS) in unresectable pancreatic cancers might be affected by the stage. Lower cancer stage and normalized bilirubin are associated with longer survival.



